HealthRX Review
Cites its own trial data properly and discloses its 503A status
Semaglutide $133/month on three months or $99 on twelve; tirzepatide $209 or $179
Overview
HealthRX prices compounded semaglutide from $133 a month on a three-month plan and $99 on a twelve-month plan, with tirzepatide at $209 and $179 respectively, flat at every dose. What lifts it above a large field of similarly priced competitors is disclosure practice. It names its pharmacy category explicitly as a licensed Section 503A compounding pharmacy, states plainly that compounded medication is not FDA-approved, cites the STEP-1 and SURMOUNT trial results with their populations and durations rather than as bare percentages, and attributes its competitor price comparison to published monthly prices at comparable clinics with a stated month. Free overnight cold shipping, all fifty states, full refund if not approved, and cancel anytime complete a structure with very little to object to.
Pros
- From $99/month semaglutide on the annual plan, $133 on three months
- Tirzepatide from $179/month on annual, $209 on three months
- Flat pricing at every dose
- Names its pharmacy category explicitly as licensed Section 503A
- States plainly that compounded medication is not FDA-approved
- Cites STEP-1 and SURMOUNT trial data with population and duration
- Attributes its competitor price comparison to a source and month
- Free overnight cold shipping, all 50 states
- Full refund if not approved; cancel anytime
Cons
- Lowest prices require a twelve-month commitment
- The specific 503A pharmacy is not named, only its category
- No lab work described as part of the programme
- Individual prescribers are not named
- Compounded medications are not FDA-approved as finished products
Key Features
Best For
Patients who want low pricing from a provider that documents its regulatory status and sources its claims
HealthRX at a Glance
Everything below reflects what HealthRX published on its own site as of August 24, 2026. Where a detail is not published, we say so rather than guessing.
- • Compounded semaglutide
- • Compounded tirzepatide
Pricing
Compounded semaglutide is $133 a month on a three-month plan and $99 on a twelve-month plan. Tirzepatide is $209 on three months and as low as $179 on twelve. Pricing is flat at every dose, and provider review, dose adjustments and overnight cold shipping are included rather than billed separately. The lowest figures require the annual commitment, so budget from the three-month rate unless you are certain.
Membership fees
None advertised; plan price is stated as inclusive.
Medication fees
- • Compounded semaglutide: $133/month (3-month plan), $99/month (12-month plan)
- • Compounded tirzepatide: $209/month (3-month plan), from $179/month (12-month plan)
- • Provider review, dose adjustments and overnight cold shipping: included
Prices change often in this category. Always confirm the current cost — including what you will pay after any introductory or promotional period — directly with HealthRX before enrolling.
Cancellation, Refunds & Payment
Support Services
Limitations to Know
- Best pricing requires a twelve-month commitment
- Specific pharmacy and individual prescribers unnamed
- No lab monitoring described
- Compounded products are not FDA-approved as finished drugs
Alternatives to HealthRX
Advertises lower still at $69 semaglutide and $119 tirzepatide, flat at every dose.
Offers FDA-approved medication alongside compounded, though billing is quarterly rather than monthly.
Flat $139.99/month with eleven clinicians named alongside NPI numbers.
Still comparing? See our full ranking of online GLP-1 providers.
HealthRX FAQs
How much does HealthRX cost?
Compounded semaglutide is $133 a month on a three-month plan and $99 on a twelve-month plan. Tirzepatide is $209 on three months and from $179 on twelve. Pricing is flat at every dose, and provider review, dose adjustments and overnight cold shipping are included.
What does 503A mean and why does HealthRX mention it?
503A pharmacies compound medications for individual patients against a specific prescription, as opposed to 503B outsourcing facilities which produce larger batches under more stringent FDA oversight. Naming the category is useful disclosure — most competitors say only that a pharmacy is licensed, which tells you considerably less.
Are the weight-loss figures HealthRX quotes reliable?
It cites average 15 percent body-weight loss at 68 weeks from STEP-1 for semaglutide and 21 percent at 72 weeks from the pivotal phase-3 tirzepatide trial. Those are the real published figures with their durations attached, which is the honest way to present them. Note they come from trials of the FDA-approved branded products, not from studies of compounded preparations.
Does the price go up as my dose increases?
No — HealthRX states the price is the same at every dose. Dose-tiered pricing is how several competitors convert an attractive starting rate into a much larger bill a few months in.
Sources consulted
Medical disclaimer: This review is for educational and comparison purposes only and is not medical advice. Rx Saver Hub is not a medical provider and does not prescribe medication. Compounded medications are not FDA-approved, and the FDA does not evaluate their safety, effectiveness or quality. Program details, pricing and availability change frequently — verify everything directly with HealthRX. Always consult a qualified healthcare provider before starting, stopping or changing any weight-loss treatment. Individual results vary.
HealthRX
Semaglutide $133/month on three months or $99 on twelve; tirzepatide $209 or $179
Quick Stats
Share Your Experience
Help others by sharing your experience with HealthRX
User Reviews
No ratings yet
Rate your experience
Click a star to rate and add a review
Questions & Discussions
Ready to Get Started with HealthRX?
Join thousands of others who have started their weight loss journey with HealthRX.
Visit HealthRX